A 21-year-old jaguar (Panthera onca) with a low body score, pale ocular mucosa, severe dehydration, and decubitus eschar was referred to our veterinary hospital. The patient died and underwent a postmortem examination to establish a diagnosis. Macroscopic evaluation revealed a reddish-black, well-defined, focally extensive mass measuring 12 cm in diameter on the visceral surface involving the left lateral lobe of the liver. The mass was surrounded by a capsule and exhibited diffuse hemorrhage, cystic areas, infiltrative zones on cross-section, and areas of morphologically compatible fatty liver degeneration. The primary differential diagnoses included adenoma, hepatocellular carcinoma, and cholangiocarcinoma. Microscopic analysis showed malignant hepatocytes forming irregular trabeculae of two or more cells, with vascular spaces between them, rudimentary acini, and neoplastic cell aggregates scattered throughout the parenchyma. Additional findings included coagulative necrosis, macrophage infiltration, hepatocyte cord formation, moderate pleomorphism, anisokaryosis, and the presence of discrete binucleated and multinucleated cells. To our knowledge, this is the first report of hepatocellular carcinoma in a jaguar. This information may aid veterinary pathologists in reporting hepatic alterations and characterizing anatomopathological findings in jaguars, representing a valuable contribution to the literature.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s11259-025-10708-w | DOI Listing |
Hepatology
March 2025
Department of Liver Surgery and Transplantation, Liver Cancer Institute and Zhongshan Hospital, Fudan University, Shanghai, China.
Background And Aims: Portal vein tumor thrombosis (PVTT), an indicator of clinical metastasis, significantly shortens hepatocellular carcinoma (HCC) patients' lifespan, and no effective treatment has been established. We aimed to illustrate mechanisms underlying PVTT formation and tumor metastasis, and identified potential targets for clinical intervention.
Approach And Results: Multi-omics data of 159 HCC patients (including 37 cases with PVTT) was analyzed to identify contributors to PVTT formation and tumor metastasis.
Radiol Med
March 2025
Department of Minimally Invasive Interventional Radiology, Sun Yat-sen University Cancer Center, Sun Yat-sen University, Dongfeng East Road 651, Guangzhou, 510260, Guangdong Province, China.
Purpose: Hepatic arterial infusion chemotherapy (HAIC) combined with lenvatinib (Len) and immune checkpoint inhibitor (ICI) in treating advanced hepatocellular carcinoma (HCC) still needs further confirmation. We aimed to evaluate the efficacy of HAIC combined with Len and ICI (HAIC + Len + ICI) versus Len alone in advanced HCC.
Methods: A total of 290 patients in Len group and 349 patients in HAIC + Len + ICI group were analysed.
Dig Dis Sci
March 2025
Department of Gastroenterology of Nara Medical University, 840 Shijo-cho, Kashihara, Nara, Japan.
Aim: The incidence of intrahepatic distant recurrence (IDR) of hepatocellular carcinoma (HCC) still remains high after radiofrequency ablation (RFA). However, serum alpha-fetoprotein (AFP) has insufficient screening power. This study aimed to identify risk factors for IDR in patients with post-RFA HCC.
View Article and Find Full Text PDFAdv Healthc Mater
March 2025
Department of Hepatobiliary and Pancreatic Surgery, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, China.
Pyroptosis, a form of programmed cell death mediated by the gasdermin family, has emerged as a promising strategy for inducing anti-tumor immunity. However, efficiently inducing pyroptosis in tumor cells remains a significant challenge due to the limited activation of key mediators like caspases in tumor tissues. Herein, a self-priming pyroptosis-inducing agent (MnNZ@OMV) is developed by integrating outer membrane vesicles (OMVs) with manganese dioxide nanozymes (MnNZ) to trigger pyroptosis in tumor cells.
View Article and Find Full Text PDFJ Vet Intern Med
March 2025
Cornell University College of Veterinary Medicine, Ithaca, New York, USA.
Introduction: Some massive or nodular liver tumors can make surgical resection dangerous. Transarterial embolization and chemoembolization recently have been evaluated in dogs and cats, but multinodular or diffuse tumors make selective embolization difficult, impractical, and may require multiple anesthetic events. Hepatic dearterialization in humans has been shown to be safe and sometimes successful in promoting temporary tumor regression.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!